In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against clinical isolates of Branhamella catarrhalis
Document Type
Article
Publication Date
1-1-1989
Description
Cefpodoxime proxetil (U-76,252; CS-807) is a new esterified oral cephem antibiotic with a broad antibacterial spectrum. Since data regarding the activity of cefpodoxime against Branhamella catarrhalis are limited, we tested its activity against 200 B. catarrhalis isolates. The drug was highly active against β-lactamase-negative and -positive isolates; 99% of all strains tested showed a cefpodoxime proxetil MIC of ≤ 2.0 μg/ml.
Citation Information
Sarubbi, F. A.; Verghese, A.; Caggiano, C.; Holtsclaw-Berk, S.; and Berk, S. L.. 1989. In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against clinical isolates of Branhamella catarrhalis. Antimicrobial Agents and Chemotherapy. Vol.33(1). 113-114. https://doi.org/10.1128/AAC.33.1.113 PMID: 2496654 ISSN: 0066-4804